Journals / Glokom Katarakt / 2013 / Cilt: 8 - Sayı: 3

Glaucoma and central nervous system changes

Glokom ve merkezi sinir sistemi değişiklikleri

Pages
212–217
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Understanding central visual system changes in glaucoma will provide insights into human glaucomatous neural degeneration and disease progression and shed light on novel strategies to prevent vision loss in glaucoma.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Glaucomatous damage has been described as a slowly progressive neuronal degenerative process along the visual pathway.
📊
Key Findings & Data:Decreased cerebral and ocular blood flow as well as impaired vascular autoregulation have been identified in glaucoma and reported to correlate with visual field loss.
💡
Conclusion & Impact:Understanding central visual system changes in glaucoma will provide insights into human glaucomatous neural degeneration and disease progression and shed light on novel strategies to prevent vision loss in glaucoma.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Glaucomatous damage has been described as a slowly progressive neuronal degenerative process along the visual pathway. Decreased cerebral and ocular blood flow as well as impaired vascular autoregulation have been identified in glaucoma and reported to correlate with visual field loss. Alterations in the retino-geniculo-cortical pathway together with the loss of retinal ganglion cells (RGC) in both experimental models and glaucoma patients have been reported. In low-tension (LTG) and pseudoexfoliative glaucoma patients, diffuse cerebral ischemic changes have been detected through magnetic resonance imaging (MRI). Understanding central visual system changes in glaucoma will provide insights into human glaucomatous neural degeneration and disease progression and shed light on novel strategies to prevent vision loss in glaucoma.

Özet

Glokomatöz hasar, görsel yolağın yavaş ilerleyici nöronal dejenerasyonu olarak tanımlanmaktadir. Azalmış serebral ve oküler kan akımı ile birlikte bozulmuş vasküler otoregülasyon, glokomda tanımlanmış ve görme alanı kaybı ile ilişkilendi- rilmiştir. Glokomda, retinal ganglion hücre (RGH) kaybı ile birlikte retino-genikulo-kortikal yolakta da değişiklikler, hem glokom hastalarında hem de glokom modelleri ile gösterilmiştir. Normotansif glokom (NTG) ve eksfoliyatif glokom hastala- rındaki yaygın serebral iskemik değişiklikler magnetik rezonans görüntüleme (MRG) ile gösterilmiştir. Glokomdaki santral görsel sistem değişikliklerinin anlaşılması ile insan glokomatöz nöronal dejenerasyon ve progresyonu daha iyi anlaşılabile- cek ve glokomda görme kaybını önlemede yeni tedavi stratejilerine ışık tutacaktır.

🔖

Cite This Article

ÜNLÜ, M., HASANREİSOĞLU, C. M., AKTAŞ, Z. (2013). Glaucoma and central nervous system changes. Glokom Katarakt, Cilt: 8 - Sayı: 3, 212–217. https://ajindex.com/articles/213651

References (15)

  1. Gupta N, Ang LC, Noel de Tilly L, et al. Human glaucoma and neural degeneration in intracranial optic nerve, lateral geniculate nucleus, and visual cortex. Br J Ophthalmol 2006;90:674-8
  2. Gupta N, Yucel YH. Glaucoma as a neurodegenerative disease. Curr Opin Ophthalmol 2007;18:110-4
  3. Yablonski M, Ritch R, Pokorny KS. Effect of decreased intracranial pressure on optic disc. Invest. Ophthalmol Vis Sci 1979;18:165
  4. Berdahl JP, Allingham RR, Johnson DH. Cerebrospinal fluid pressure is decreased in primary open-angle glaucoma. Ophthalmology 2008;115:763-8
  5. Ren R, Jonas JB, Tian G, et al. Cerebrospinal fluid pressure in glaucoma: a prospective study. Ophthalmology 2010;117:259- 66
  6. Jaggi GP, Miller NR, Flammer J, et al. Optic nerve sheath diameter in normal-tension glaucoma patients. Br J Ophthalmol. 2012;96:53-56
  7. Killer HE, Miller NR, Flammer J, et al. Cerebrospinal fluid exchange in the optic nerve in normaltension glaucoma. Br J Ophthalmol 2012;96:544-8
  8. Leske MC, Heijl A, Hussein M, et al. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol 2003;121:48-56
  9. Yucel YH, Zhang Q, Gupta N, et al. Loss of neurons in magnocellular and parvocellular layers of the lateral geniculate nucleus in glaucoma. Arch Ophthalmol 2000;118:378-84
  10. Yucel YH, Zhang Q, Weinreb RN, et al. Atrophy of relay neurons in magno- and parvocellular layers in the lateral geniculate nucleus in experimental glaucoma. Invest Ophthalmol Vis Sci 2001;42:3216-22
  11. Weber AJ, Chen H, Hubbard WC, et al. Experimental glaucoma and cell size, density, and number in the primate lateral geniculate nucleus. Invest Ophthalmol Vis Sci 2000;41:1370-9
  12. Yuksel N, Anik Y, Altintas O, et al. Magnetic resonance imaging of the brain in patients with pseudoexfoliation syndrome and glaucoma. Ophthalmologica 2006;220:125-30
  13. Stroman GA, Stewart WC, Golnik KC, et al. Magnetic resonance imaging in patients with low tension glaucoma. Arch Ophthalmol 1995;113:168-72
  14. Ong K, Farinelli A, Billson F, et al. Comparative study of brain magnetic resonance imaging findings in patients with low-tension glaucoma and control subjects. Ophthalmology 1995;102:1632-8 15. Zakharov A, Papaiconomou C, Djenic J, et al. Lymphatic cerebrospinal fluid absorption pathway in neonatal sheep revealed by subarachnoid injection of Microfil. Neuropathol Appl Neurobiol 2003;29:563
  15. Meyer-Schwickerath R, Kleinwachter T, Firsching R, et al. Cen